enVVeno Medical (NVNO) Research & Development (2017 - 2026)

enVVeno Medical's Research & Development history runs 10 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Research & Development fell 17.44% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $9.5 million (down 18.88% YoY), while the FY2025 annual figure was $10.0 million, down 18.52% from the prior year.
• Research & Development was $2.1 million for Q1 2026 at enVVeno Medical, up from $1.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $4.2 million in Q2 2023 to a low of $1.6 million in Q1 2022.
• Historically, Research & Development has averaged $2.8 million across 5 years, with a median of $2.8 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Research & Development soared 181.93% in 2022, then slumped 44.55% in 2025.
• A 5-year view of Research & Development shows it stood at $2.8 million in 2022, then increased by 6.58% to $3.0 million in 2023, then increased by 17.85% to $3.5 million in 2024, then plunged by 44.55% to $1.9 million in 2025, then rose by 8.37% to $2.1 million in 2026.
• The last three Research & Development figures came in at $2.1 million (Q1 2026), $1.9 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.